prevention

Dr. M’s Women and Children First Podcast #109: Nutrition, Epigenetic Change and Childhood Disease



Nothing in biology is random.
Not growth.
Not metabolism.
Not disease.
What we will explore today is the reality that the earliest inputs in life: nutrition, environment, signaling,
don’t just influence outcomes…
They shape them.
They write the first draft.
And if you understand that, if you truly let that land,
then everything about how we approach pregnancy, childhood, and prevention begins to shift.
From reaction…to intention.
From downstream management…to upstream design.

Why This Conversation Matters
This episode is not just another discussion.
In many ways, it is ground zero.
Because if you don’t understand this layer, the imprinting, the epigenetic programming, the responsiveness of biology to environment, then everything that follows in this podcast…becomes harder to fully see.
But once you do see it, the picture sharpens.
You begin to understand:why trajectories diverge early, why children present so differently and why the same diagnosis can have completely different roots.

This is the beginning of a new map.
And maps matter.

Gratitude to Today’s Guests
I want to take a moment to acknowledge the voices you heard today—because this kind of thinking doesn’t happen by accident.

Lucia Aronica
Dr. Aronica is a Stanford scientist and a global authority in nutritional epigenetics, helping clinicians understand that food is not simply fuel—it is biological information that actively programs gene expression.

She created Stanford’s first courses in nutritional epigenetics and pioneered the Epinutrition framework, a clinical model that reframes nutrition as signaling, not supplementation.

You may recognize her from the Netflix documentary You Are What You Eat: A Twin Experiment, and she is now launching the world’s first Clinical Epinutrition Certification, training health professionals to use food as epigenetic medicine.

Emily Stone Rydbom
Emily is a clinical nutritionist, researcher, and digital health founder working at the frontier of precision maternal nutrition.

As Founder and CEO of GrowBaby Health, and through her work with GrowHealth Technologies, she is building AI-enabled systems that integrate nutrition directly into standard obstetric care. With over 14 years of clinical experience, she has helped pioneer the “Standard of Care PLUS” model, demonstrating meaningful reductions in preterm birth and gestational diabetes in high-risk populations.

She is also a co-investigator on the ROOT Study—bringing this work directly into real-world maternal care here in North Carolina.

Samantha N. Fessler
Dr. Fessler brings a deep scientific lens to the intersection of metabolism, inflammation, and perinatal nutrition.
With a PhD in Exercise and Nutritional Sciences from Arizona State University, her work has focused on how nutritional strategies can modulate the interplay between immune signaling and metabolic function to improve outcomes for mothers and children.

As Director of Scientific Affairs at Needed, she helps translate rigorous science into actionable, evidence-based approaches that clinicians and families can actually use.

Randy L. Jirtle
And finally, Dr. Randy Jirtle—joining us again—whose work, quite simply, changed how we understand biology.
A pioneer in epigenetics and genomic imprinting, Dr. Jirtle’s research on the agouti mouse model demonstrated for the first time that environmental inputs—particularly nutrition and chemical exposure—could directly alter gene expression across generations. His work reframed the gene from a fixed sentence…to a responsive system.

In fact, Time Magazine once described it this way:“A gene represents less of an inexorable sentence and more of an access point for the environment to modify the genome.”

He is a Professor of Epigenetics at North Carolina State University and Senior Scientist at University of Wisconsin–Madison and remains, at his core, a deeply curious thinker.

And that curiosity… is what moved this field forward.

Final Thought: If there is one takeaway from today, it is this: The environment is not acting on the child. The child is responding to the environment.

And that response…is being written into biology.

Dr. M

Dr. M’s Women and Children First Podcast #106: Nayan Patel, PharmD – Glutathione


Welcome back to Dr. M’s Women and Children Firsts Podcast. Today’s conversation sits at the crossroads of chemistry, skepticism, and clinical innovation.

Our guest is Nayan Patel, a pharmacist with more than three decades inside the world of drug formulation and delivery. He is an alumnus of the University of Southern California School of Pharmacy, where he now serves as adjunct faculty, teaching advanced biochemistry and compounding science. Over the years, he has become an international educator on one molecule that refuses to stay quiet: glutathione.

Dr. Patel is the founder of Auro Wellness, launched in 2011 with a specific mission—stabilize glutathione and solve its delivery problem. His work led to the development of the Auro GSH™ Antioxidant Delivery System, a topical approach designed to improve absorption of this notoriously fragile molecule. He is also the author of The Glutathione Revolution, a deep dive into how glutathione influences detoxification, aging, energy production, and immune resilience.

If you’ve spent time in integrative medicine, you’ve heard glutathione called the “master antioxidant.” That phrase can sound like marketing, but the biology is real. Glutathione is a three–amino acid peptide central to redox balance, mitochondrial function, immune signaling, and cellular survival. It does not just neutralize oxidative stress; it regulates how cells respond to it.

The challenge is delivery. Oral glutathione is largely broken down in the gut. IV glutathione works, but it’s impractical for most families. Precursors like NAC depend on intact metabolic pathways that may not be operating optimally in states of chronic stress or inflammation.
Dr. Patel asked a disruptive question: what if the bottleneck isn’t production—but delivery?

Today we unpack the science and the skepticism around transdermal glutathione. Can a molecule like this meaningfully cross the skin barrier? What does stabilization actually require? And how does independent pharmaceutical innovation differ from traditional drug development pathways, which are often constrained by economics as much as biology?

For those of us caring for women and children—where oxidative stress, immune dysregulation, mitochondrial strain, and toxic burden intersect in everything from complicated pregnancies to neurodevelopmental challenges—this conversation matters. Not as a silver bullet. Not as a miracle spray. But as an exploration of foundational physiology and thoughtful delivery science.

This is a discussion about how molecules move, how systems adapt, and how asking better questions can reshape clinical practice.
Let’s dive in.

Dr. M

Auro Wellness

Dr. M’s Women and Children First Podcast #69 Repost – Stephen Porges, Ph.D. – Polyvagal Theory


This week I sit down with Dr. Stephen Porges, a Distinguished University Scientist at Indiana University where he is the founding director of the Traumatic Stress Research Consortium. He is Professor of Psychiatry at the University of North Carolina, and Professor Emeritus at both the University of Illinois at Chicago and the University of Maryland.

He served as president of the Society for Psychophysiological Research and the Federation of Associations in Behavioral & Brain Sciences and is a former recipient of a National Institute of Mental Health Research Scientist Development Award. He has published more than 400 peer-reviewed papers across several disciplines including anesthesiology, biomedical engineering, critical care medicine, ergonomics, exercise physiology, gerontology, neurology, neuroscience, obstetrics, pediatrics, psychiatry, psychology, psychometrics, space medicine, and substance abuse. In 1994 he proposed the Polyvagal Theory, a theory that links the evolution of the mammalian autonomic nervous system to social behavior and emphasizes the importance of physiological state in the expression of behavioral problems and psychiatric disorders. The theory is leading to innovative treatments based on insights into the mechanisms mediating symptoms observed in several behavioral, psychiatric, and physical disorders.

He is the author of multiple books on his Polyvagal Theory: including the Neurophysiological foundations of Emotions, Attachment, Communication, and Self-regulation, as well as Polyvagal Safety: Attachment, Communication, Self-Regulation. His newest book cowritten with his son is called Our Polyvagal World, How Safety and Trauma Change Us. Dr. Porges is the creator of a music-based intervention, the Safe and Sound Protocol ™ (SSP), which is used by therapists to improve social engagement, language processing, and state regulation, as well as to reduce hearing sensitivities.

This is such a fascinating conversation. He brings the worlds of psychiatry and anthropological physiology into union for us to understand the why of trauma reactions and the future unwinding that is now possible. This is a must listen to conversation if you know anyone with trauma history.

Please enjoy my conversation with Professor Porges,
Dr. M

Dr. M’s Women and Children First Podcast #100 Wayne Koontz, MD – Vaccines and Disease over 50 years

Today on Dr. M’s Women and Children First Podcast, we welcome Dr. Wayne Koontz, a founding partner at Salisbury Pediatric Associates in Salisbury North Carolina, where he has spent over 5 decades caring for generations of families with compassion, wisdom, and a deep commitment to community health.

Dr. Koontz earned his Undergraduate degree and his Doctor of Medicine from Wake Forest University, where his early love of science and service began to take shape. He went on to complete his pediatric residency at Dallas Children’s Medical Center, part of the University of Texas Southwestern Medical School, where he received outstanding training in both academic and clinical pediatrics.

As one of the founding physicians at Salisbury Pediatrics, Dr. Koontz helped to build a model of child-centered, family-oriented care that has served the Rowan County. His commitment to children’s well-being extends beyond the clinic, reflecting a lifelong dedication to preventive medicine, developmental health, and the nurturing of strong physician–family relationships.

It’s an honor to have Dr. Koontz with us today to share his clinical insights as they relate to infection and vaccination from a longevity based pediatric career. Dr. Koontz has a unique perspective to share as his 50 plus years of experience cover the prevaccine infectious disease based practice of pediatric medicine all the way to the current vaccine centric and reduced infectious disease burden reality. That is a timeline worthy of exploration.

So lets explore.

Dr. M

Dr. M’s SPA Newsletter Volume 15 Issue 22/23/24 – Acetaminophen and Autism

Review Part III – after the Attia Podcast

After completing the interview with Dr. William Parker and now listening to Peter Attia’s analysis, let us look again at this question. I repeat that the initial question has not changed for me. The first and most fundamental question to ask is this: What is the true value of acetaminophen in health compared with the potential risk if the associated findings are indeed correct?

My response to this question has been altered by the analysis so far.

I love this from Dr. Attia: “Some people might be wondering, why did you just take so long to explain all this to us? Why don’t you just give us the answer? I just want the sound bite, man

Peter’s reply, “If you just want sound bites, you’re never going to learn.”

Honestly, if you just want sound bites, this isn’t the podcast for you. But if you actually want to be able to learn to think for yourself, then that’s what we’re here to do. And that’s the reason we killed ourselves over the past week to put together the most thorough gathering of all the data we could find and the most intense night-weekend analysis possible. “

I agree! I believe that the science and data are key. So here goes – round three!…..

Dr. M

 

Dr. M’s Women and Children First Podcast #98 William Parker, PhD – Acetaminophen and Autism – What Do We Know in 2025?

Welcome to Dr. M’s Women & Children First Podcast, where we engage with pioneering voices at the intersection of science, healthcare, and the well-being of families.

Today, I’m honored to introduce Dr. William Parker, PhD. Dr. Parker is perhaps best known for discovering the function of the human appendix, but his contributions to science extend far beyond that single discovery. He studied biology and chemistry as an undergraduate before earning his PhD in Chemistry from the University of Nebraska–Lincoln in 1992. Since the 1980s, he has conducted innovative research, publishing more than 150 peer-reviewed articles that span immune function, microbiome science, and human health.

Dr. Parker was the first to compare immune systems in wild animals with those of their laboratory counterparts, and among the first to conclude that changes in the human “biota”, the symbiotic organisms living within us, brought on by modern society can contribute to depression and anxiety. After nearly three decades at Duke University, where he served as associate professor and research leader, he founded WPLab, Inc., a nonprofit dedicated to understanding and educating about the causes of chronic inflammatory diseases in high-income societies.

Currently a visiting scholar at the University of North Carolina, Dr. Parker collaborates widely with colleagues from Duke University, University of Montreal, Czech Academy of Sciences, University of Groningen, University of Colorado Boulder, and scientists across the pharmaceutical industry.

In recent years, he has turned his attention to a provocative and urgent question: the potential links between early acetaminophen exposure and autism spectrum outcomes. His current work combines mechanistic and epidemiologic approaches to explore how acetaminophen’s effects on human physiology at critical stages of development might influence neurodevelopment.

In our conversation, we’ll explore:

  • The evidence and hypotheses behind acetaminophen’s potential role in autism risk
  • What families and clinicians should know: what’s plausible, what remains speculative, and where research is heading next

I’m thrilled to share this episode with Dr. Parker, whose intellectual curiosity, scientific rigor, and courage to ask difficult questions embody the spirit of this show.

Dr. M

Dr. M’s Women and Children First Podcast #97 Paul Offit, MD – Vaccines – What Do We Know in 2025 Part 2?

Welcome back to Dr. M’s Women & Children First, where we explore the front lines of children’s health and what matters most for our families.

Today I’m honored to bring you Dr. Paul A. Offit, the Director of the Vaccine Education Center and Professor of Pediatrics in the Division of Infectious Diseases at Children’s Hospital of Philadelphia. He also holds the Maurice R. Hilleman Professorship of Vaccinology at the University of Pennsylvania.

Dr. Offit is a globally recognized expert in virology and immunology. He has served on the CDC’s Advisory Committee on Immunization Practices and FDA’s Vaccines and Related Biological Products Advisory Committee. He’s co-editor of the seminal vaccine textbook Vaccines, and for decades has been one of the clearest scientific voices defending evidence, transparency, and children’s health.

This week, we’ll dig into COVID, vaccine policy, and what’s ahead for children in light of the latest shifts. Among current headlines: Healthy children and pregnant women are no longer being uniformly recommended for COVID vaccines by Health Secretary Robert F. Kennedy Jr., a decision that’s stirring debate among pediatricians and public health experts like Dr. Offit. He’s sharply voiced concerns about removing key vaccine recommendations without new data, and about the broader implications of loosening vaccine guidance for the public good.

In this conversation, we’ll cover:

  • What the science says now about bivalent COVID vaccines in kids

  • How recent policy changes affect vaccine access, trust, and safety

  • What parents need to know—what’s changed, what’s stable, and what remains uncertain

This is my third time talking with Dr. Offit, and as always, I expect you’ll leave with clarity, evidence, and questions worth sharing.

I hope you enjoy this conversation.

Let’s dive in.

Dr. M

1 2 13